Human medicines European public assessment report (EPAR): Tobramycin PARI, tobramycin, Respiratory Tract Infections,Cystic Fibrosis, Date of authorisation: 18/02/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-106e820 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Cayston, aztreonam, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 21/09/2009, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-145d598 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Quinsair, levofloxacin, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 25/03/2015, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-58725a ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Quinsair, levofloxacin, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 25/03/2015, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-543da3 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Respiratory Tract Infections,Cystic Fibrosis, Date of authorisation: 18/02/2019, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a59724 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vantobra, tobramycin, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 18/03/2015, Revision: 3, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-ed3b51 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Tobramycin PARI, tobramycin, Respiratory Tract Infections,Cystic Fibrosis, Date of authorisation: 18/02/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-105efa4 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 20/07/2011, Revision: 15, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1ecee2e ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vantobra, tobramycin, Cystic Fibrosis,Respiratory Tract Infections, Date of authorisation: 18/03/2015, Revision: 3, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-eceeb3 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Respiratory Tract ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vabomere, meropenem / vaborbactam, Urinary Tract Infections,Bacteremia,Bacterial Infections,Respiratory Tract Infections,Pneumonia,Pneumonia, Ventilator-Associated, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6ac6ef ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Respiratory Tract ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vaborem, meropenem / vaborbactam, Urinary Tract Infections,Bacteremia,Bacterial Infections,Respiratory Tract Infections,Pneumonia,Pneumonia, Ventilator-Associated, Date of authorisation: 20/11/2018, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-18120b8 ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Respiratory Tract ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text